Acute promyelocytic leukemia with <i>TTMV::RARA</i> fusion potentially responds to all-trans retinoic acid/arsenic trioxide treatment
Not available.
Saved in:
| Main Authors: | Qingyu Xu, Yebo Peng, Shu Sun, Yanru Zhang, Ting Shi, Xiaohong Kuang, Yin Wu, Hong-Hu Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-01-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11906 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of arsenicum trioxide and all trans retinoic acid in the treatment of relapsed acute promyelocytic leukemia
by: A. N. Sokolov, et al.
Published: (2015-06-01) -
Venetoclax plus arsenic and all-trans retinoic acid in patients with relapsed/refractory acute promyelocytic leukemia
by: Bingqian Jiang, et al.
Published: (2025-07-01) -
Mutation in the Unrearranged PML Allele Confers Resistance to Arsenic Trioxide in Acute Promyelocytic Leukemia
by: Pei-Han Yu, et al.
Published: (2025-01-01) -
All -Trans-Retinoic Acid–induced pseudotumor cerebri in Acute Promyelocytic Leukemia
by: anoop tm
Published: (2014-08-01) -
Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.
by: Ezhilarasi Chendamarai, et al.
Published: (2015-01-01)